The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | Current and emerging treatment options for anemia in MF
Francesco Passamonti, MD, University of Insubria, Varese, Italy, gives an overview of treatment options available for patients with myelofibrosis (MF) and anemia, including momelotinib, pacritinib, and combinations with ruxolitinib. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
